News Synairgen under the weather after AZ halts asthma trial AZ assessing drug's future following trial disappointment.
News Giving antibiotics to children increases allergy risk Antibiotics linked with asthma and eczema link.
Digital and Social Media Vectura and Propeller to co-develop digital inhaler Respiratory specialist company Vectura is to collaborate with tech firm Propeller to produce a digitally-connected set of inhalers.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.